Impact of the PEAR 1 polymorphism on clinical outcomes in Chinese patients receiving dual antiplatelet therapy after percutaneous coronary intervention

Pharmacogenomics,Volume 23, Issue 11, Page 639-648, July 2022.

https://www.futuremedicine.com/doi/abs/10.2217/pgs-2022-0033?ai=rs&mi=0&af=R

Source: Future Medicine: Pharmacogenomics - July 26, 2022 Category: Genetics & Stem Cells Authors: Xinyuan Hu Chaoxi Liu Mingyou Zhang Weihua Zhang Source Type: research

More News: Angioplasty | China Health | Coronary Angioplasty | Genetics | Percutaneous Coronary Intervention